Phio Pharmaceuticals (PHIO)
(Delayed Data from NSDQ)
$3.29 USD
+0.39 (13.45%)
Updated Sep 13, 2024 03:59 PM ET
After-Market: $3.29 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 35% (89 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.58 | 9.99 |
Current Quarter Estimate | NA | -1.17 | 61.00 |
Year Ago Quarter Estimate | -10.26 | -0.06 | 54.84 |
Next Quarter Estimate | NA | -1.92 | 63.00 |
Next Year Estimate | NA | 12.59 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | NA | 20.10 | 15.70 |
Next Year | NA | 15.60 | 11.30 |
Last 5 Years | NA | 7.90 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -1.44 |
Price/Book (MRQ) | 0.44 | 1.54 |
Price/Cash Flow (MRFY) | NA | 9.03 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -61.35% |
Return on Equity (TTM) | -142.68% | -59.40% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.